Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US
Sponsor: Regeneron Pharmaceuticals
Summary
This study will test olatorepatide (study drug) to determine how safe and effective this drug is and how easily your body can accept this drug without causing side effects, as well as how the drug is processed in the body by participants with overweight or obesity. The study will test how safe and effective the study drug works compared to placebo in people who are overweight or obese but do not have diabetes. The study is looking at: * What side effects the study drug might cause * How much the study drug is in the blood at different times * How well the study drug works * If your body makes antibodies to the study drug, as this may cause the study drug to not work as well
Official title: A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Pharmacokinetics, Safety, Tolerability, and Efficacy of Olatorepatide, a GLP-1/GIP Receptor Agonist, in Participants Living With Overweight or Obesity in the US
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-03-16
Completion Date
2026-12-18
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
Olatorepatide
Administered per the protocol
Placebo
Administered per the protocol
Locations (1)
Flourish Research - San Antonio Medical Trials
San Antonio, Texas, United States